Dr Reddys Laboratories (RDY) Non-Current Assets (2009 - 2026)
Dr Reddys Laboratories' Non-Current Assets was $2.92 billion in the quarter ended Jun 30, 2026, down 0.1% from $2.92 billion a year earlier and down 3.9% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Non-Current Assets (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Non-Current Assets at Dr Reddys Laboratories came in at $2.96 billion, up 3.9% from the prior year.
- Non-Current Assets has now increased for three consecutive years, with a five-year compound annual growth rate of 13.0% (years ended Mar 2021 to Mar 2026).
- In earlier years, Non-Current Assets was $2.84 billion in the year ended Mar 31, 2025 (+70.0%), $1.67 billion in the year ended Mar 31, 2024 (+19.7%), $1.4 billion in the year ended Mar 31, 2023 (-4.4%) and $1.46 billion in the year ended Mar 31, 2022 (-8.7%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Non-Current Assets since the quarter ended Mar 31, 2025.
- Compared with a year earlier, Non-Current Assets was higher in seven of the last eight quarters, with growth averaging 37.7%.
- The best year-over-year quarter for Non-Current Assets over five years was the quarter ended Dec 31, 2024 (growth of 67.4%); the worst was the quarter ended Dec 31, 2022 (a decline of 9.4%).
- Per Business Quant data, RDY's Non-Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $3.03 billion (quarter ended Mar 31, 2026), $2.98 billion (quarter ended Dec 31, 2025) and $3.01 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 2.92 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.92 Bn |
| Mar 31, 2026 | 3.03 Bn |
| Dec 31, 2025 | 2.98 Bn |
| Sep 30, 2025 | 3.01 Bn |
| Jun 30, 2025 | 2.92 Bn |
| Mar 31, 2025 | 2.80 Bn |
| Dec 31, 2024 | 2.70 Bn |
| Sep 30, 2024 | 2.60 Bn |
| Jun 30, 2024 | 1.75 Bn |
| Mar 31, 2024 | 1.68 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 1.56 Bn |
| Jun 30, 2023 | 1.52 Bn |
| Mar 31, 2023 | 1.43 Bn |
| Dec 31, 2022 | 1.40 Bn |
| Sep 30, 2022 | 1.45 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.54 Bn |
| Sep 30, 2021 | 1.56 Bn |
API Access
Dr Reddys Laboratories Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();